Document Detail


Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease.
MedLine Citation:
PMID:  9456484     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The use of inhaled nitric oxide as a selective pulmonary vasodilator has expanded to include patients with congenital heart disease and pulmonary hypertension. The therapeutic and diagnostic roles of inhaled nitric oxide offer additional alternatives and benefits to these patients with pulmonary hypertension, particularly in the postoperative setting. This article reviews the background, mechanism of action, toxicities, and current clinical applications of inhaled nitric oxide in the child with congenital heart disease and pulmonary hypertension.
Authors:
J P Kovalchin; A R Mott; K L Rosen; T F Feltes
Related Documents :
21515414 - Exhaled nitric oxide and pulmonary artery pressures during graded ascent to high altitude.
9187594 - Positive end-expiratory pressure increases pulmonary venous vascular resistance in pati...
3684374 - Bipyridine derivatives lower arteriolar resistance and improve left ventricular functio...
15194174 - Cellular and molecular pathobiology of pulmonary arterial hypertension.
18308894 - Acute pseudoaneurysm of the femoral artery after repeated trauma in full-contact karate...
11795304 - Abdominal aortic aneurysm as an autoimmune disease.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital     Volume:  24     ISSN:  0730-2347     ISO Abbreviation:  Tex Heart Inst J     Publication Date:  1997  
Date Detail:
Created Date:  1998-03-18     Completed Date:  1998-03-18     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  8214622     Medline TA:  Tex Heart Inst J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  308-16     Citation Subset:  IM    
Affiliation:
Lillie Frank Abercrombie Section of Cardiology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Inhalation
Child
Heart Defects, Congenital / complications*,  surgery
Humans
Hypertension, Pulmonary* / diagnosis,  etiology,  therapy
Infant, Newborn
Nitric Oxide / administration & dosage,  adverse effects,  diagnostic use,  physiology,  therapeutic use*
Vasodilator Agents / administration & dosage,  adverse effects,  diagnostic use,  therapeutic use*
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 10102-43-9/Nitric Oxide
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Congenital complete atrioventricular block.
Next Document:  One-stage neonatal repair of complex aortic arch obstruction or interruption. Recent experience at T...